![Frontiers | Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia Frontiers | Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia](https://www.frontiersin.org/files/Articles/659253/fonc-11-659253-HTML/image_m/fonc-11-659253-g001.jpg)
Frontiers | Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia
![Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells. Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells.](http://www.cancerhelpessentiahealth.org/images/cdr/live/CDR526219-750.jpg)
Myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy blood cells.
![Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward? | Leukemia Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward? | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01498-6/MediaObjects/41375_2021_1498_Fig1_HTML.png)
Blasts” in myeloid neoplasms – how do we define blasts and how do we incorporate them into diagnostic schema moving forward? | Leukemia
![Qasim Hussaini, MD on Twitter: "Which white blood cell are you at #ASH21? #ASHTrainee https://t.co/ltFZLqvZ0X" / Twitter Qasim Hussaini, MD on Twitter: "Which white blood cell are you at #ASH21? #ASHTrainee https://t.co/ltFZLqvZ0X" / Twitter](https://pbs.twimg.com/media/FGVox-cX0AoeLZY.jpg)
Qasim Hussaini, MD on Twitter: "Which white blood cell are you at #ASH21? #ASHTrainee https://t.co/ltFZLqvZ0X" / Twitter
![Cancers | Free Full-Text | Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets Cancers | Free Full-Text | Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets](https://www.mdpi.com/cancers/cancers-14-01873/article_deploy/html/images/cancers-14-01873-g001-550.jpg)
Cancers | Free Full-Text | Early T-Cell Precursor ALL and Beyond: Immature and Ambiguous Lineage T-ALL Subsets
![IJMS | Free Full-Text | Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia IJMS | Free Full-Text | Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia](https://www.mdpi.com/ijms/ijms-23-10529/article_deploy/html/images/ijms-23-10529-g001.png)
IJMS | Free Full-Text | Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia
![Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia | Leukemia Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01647-5/MediaObjects/41375_2022_1647_Fig1_HTML.png)
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia | Leukemia
![In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties: Cancer Cell In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties: Cancer Cell](https://www.cell.com/cms/attachment/2041070235/2055009691/gr1.jpg)
In Childhood Acute Lymphoblastic Leukemia, Blasts at Different Stages of Immunophenotypic Maturation Have Stem Cell Properties: Cancer Cell
![EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes | Leukemia EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2012.120/MediaObjects/41375_2012_Article_BFleu2012120_Fig1_HTML.jpg)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes | Leukemia
Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape | Haematologica
![Vivek Patel, MD on Twitter: "Blast Types for Acute Leukemia: AML = immature + myeloid markers B-ALL = immature + B cell markers T-ALL = immature + T cell markers Mixed Phenotype Vivek Patel, MD on Twitter: "Blast Types for Acute Leukemia: AML = immature + myeloid markers B-ALL = immature + B cell markers T-ALL = immature + T cell markers Mixed Phenotype](https://pbs.twimg.com/media/FJzV7jrXEAMc7Et.jpg)
Vivek Patel, MD on Twitter: "Blast Types for Acute Leukemia: AML = immature + myeloid markers B-ALL = immature + B cell markers T-ALL = immature + T cell markers Mixed Phenotype
![Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia | Blood Cancer Journal Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-022-00712-7/MediaObjects/41408_2022_712_Fig1_HTML.png)
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia | Blood Cancer Journal
![JCM | Free Full-Text | Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going JCM | Free Full-Text | Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going](https://pub.mdpi-res.com/jcm/jcm-09-01714/article_deploy/html/images/jcm-09-01714-ag.png?1592203371)
JCM | Free Full-Text | Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going
![The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease | Scientific Reports The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-56126-2/MediaObjects/41598_2019_56126_Fig1_HTML.png)